1st Quarter - Report
W STRATEGIES, LLC for GENZYME CORPORATION
Firm
Client
Income
$30,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Monitored H.R. 3630: Temporary Payroll Tax Cut Continuation Act of 2011 as it relates to Medicare reimbursement for Part B drugs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Health Issues HCR
Monitoring the implementation of the Patient Protection and Affordable Care Act, including provisions related to a regulatory pathway for biosimilars, and provisions related to orphan drugs and opposing efforts in the President's Budget to alter that pathway. H.R. 4132: Faster Access to Specialized Treatments Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.